- Home
- CSAI vs DTIL Comparison
CSAI vs DTIL Comparison
Compare CSAI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAI
- DTIL
- Stock Information
- Founded
- CSAI N/A
- DTIL 2006
- Country
- CSAI
- DTIL United States
- Employees
- CSAI 18
- DTIL N/A
- Industry
- CSAI
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CSAI
- DTIL Health Care
- Exchange
- CSAI NYSE
- DTIL Nasdaq
- Market Cap
- CSAI 53.1M
- DTIL 51.6M
- IPO Year
- CSAI N/A
- DTIL 2019
- Fundamental
- Price
- CSAI $2.57
- DTIL $4.83
- Analyst Decision
- CSAI
- DTIL Strong Buy
- Analyst Count
- CSAI 0
- DTIL 2
- Target Price
- CSAI N/A
- DTIL $47.00
- AVG Volume (30 Days)
- CSAI N/A
- DTIL 74.8K
- Earning Date
- CSAI N/A
- DTIL 05-15-2025
- Dividend Yield
- CSAI N/A
- DTIL N/A
- EPS Growth
- CSAI N/A
- DTIL N/A
- EPS
- CSAI N/A
- DTIL N/A
- Revenue
- CSAI N/A
- DTIL $51,141,000.00
- Revenue This Year
- CSAI N/A
- DTIL N/A
- Revenue Next Year
- CSAI N/A
- DTIL $30.20
- P/E Ratio
- CSAI N/A
- DTIL N/A
- Revenue Growth
- CSAI N/A
- DTIL N/A
- 52 Week Low
- CSAI N/A
- DTIL $3.61
- 52 Week High
- CSAI N/A
- DTIL $13.32
- Technical
- Relative Strength Index (RSI)
- CSAI N/A
- DTIL 46.95
- Support Level
- CSAI N/A
- DTIL $4.51
- Resistance Level
- CSAI N/A
- DTIL $5.10
- Average True Range (ATR)
- CSAI 0.00
- DTIL 0.27
- MACD
- CSAI 0.00
- DTIL -0.00
- Stochastic Oscillator
- CSAI 0.00
- DTIL 40.00
About CSAI CLOUDASTRUCTURE INC
Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.